5 640 Cases of Outpatient Genital Tract Infection Caused by Mycoplasma and Analysis of Drug Resistance
10.6039/j.issn.1001-0408.2016.05.14
- VernacularTitle:5640例门诊患者生殖道支原体属感染状况及耐药率分析
- Author:
Xin ZHENG
;
Anying LI
;
Zhong LIU
;
Anni LU
;
Haolong WANG
;
Kun PANG
- Publication Type:Journal Article
- Keywords:
Mycoplasma;
Ureaplasma urealyticum;
Mycoplasma hominis;
Genital tract infection;
Drug resistance;
Outpatient
- From:
China Pharmacy
2016;27(5):622-624
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To provide reference for the rational use of antibiotics in outpatients who had genital tract Mycoplas-ma infections in Yulin area. METHODS:Using the integration culture plate,19 836 outpatient's specimens with suspected Myco-plasma infection from Yulin Maternal and Child Health Care Hospital during 2012 to 2014 were tested,and then the results of drug susceptibility test were retrospectively analyzed. RESULTS:In the total of 19 836 inspected specimens,5 640 cases were positive with the rate of 28.4%. The positive rate of Ureaplasma urealyticum(Uu),Mycoplasma hominis(Mh),mixed(Uu+ Mh)infection were 88.0%,3.8% and 8.2% respectively. The positive rate of male patient with Mycoplasma infection was lower than female pa-tient(P<0.05). Male and female patients with positive maximum age respectively at the age of 25 to 40 (81.3%) and 20 to 35 years old(78.6%). From 2012 to 2014,Mycoplasma showed different degree of drug resistance to 9 kinds of antibiotics. In gener-al,the resistance rate of Uu to lincocin was close to 100%,Mh to erythromycin,roxithromycin and azithromycin were higher than 70%,and those of Uu+Mh were lower than 10% only to josamcine,minocycline and doxycycline. CONCLUSIONS:During 2012 to 2014,the rate of genital tract Mycoplasma infection in male and female outpatients of Yulin region increased year by year,and the infection mainly caused by Uu with a serious drug resistance. We should also pay attentions to the increase of Mh infection and mixed infection. Josamycin,minocycline and doxcycline can be used as a drug choice for empiric preferred treatment,and other an-tibiotics should be used based on antibiotics susceptibility test results.
